{"id":7721,"date":"2021-12-16T10:29:56","date_gmt":"2021-12-16T15:29:56","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/tesamorelin-usan-tesamorelin-cas-218949-48-5-para-el-tratamiento-del-sindrome-del-trastorno-del-metabolismo-de-los-lipidos-asociado-al-vih\/"},"modified":"2021-12-16T10:29:56","modified_gmt":"2021-12-16T15:29:56","slug":"tesamorelin-usan-tesamorelin-cas-218949-48-5-para-el-tratamiento-del-sindrome-del-trastorno-del-metabolismo-de-los-lipidos-asociado-al-vih","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/es\/product\/tesamorelin-usan-tesamorelin-cas-218949-48-5-para-el-tratamiento-del-sindrome-del-trastorno-del-metabolismo-de-los-lipidos-asociado-al-vih\/","title":{"rendered":"Tesamorelin (usan) \/ Tesamorelin CAS 218949-48-5 Para el tratamiento del s\u00edndrome del trastorno del metabolismo de los l\u00edpidos asociado al VIH"},"content":{"rendered":"

Tesamorelin (usan) \/ Tesamorelin CAS 218949-48-5 Para el tratamiento del s\u00edndrome del trastorno del metabolismo de los l\u00edpidos asociado al VIH<\/strong><\/h2>\n

Nombre del producto: Tesamorelin (usan)
\n Sin\u00f3nimos: D06655; Tesamorelin (usan); TesamorelinAcetate; P\u00e9ptidos farmac\u00e9uticos m\u00e1s vendidos 2 mg Tesamorelin 99%; Tesamorelin (usan) USP \/ EP \/ BP
\n CAS: 218949-48 -5
\n MF:
\n MW: 0
\n EINECS: 603-809-2
\n Categor\u00edas de productos:
\n Archivo Mol: Archivo Mol <\/p>\n

Tesamorelin es un p\u00e9ptido sint\u00e9tico que consiste en los 44 amino\u00e1cidos de hGRF con la adici\u00f3n de un grupo de \u00e1cido trans-3-hexenoico.Tesamorelin (tambi\u00e9n conocida como Egrifta) es una forma sint\u00e9tica de hormona liberadora de hormona del crecimiento que se utiliza en el tratamiento de la lipodistrofia asociada al VIH. fibroblastos de una manera dependiente de la dosis, como lo revela el ensayo de migraci\u00f3n del filtro transwell. BPC 157 tambi\u00e9n aceler\u00f3 de forma dependiente de la dosis la propagaci\u00f3n de los fibroblastos del tend\u00f3n en las placas de cultivo. La formaci\u00f3n de actina F detectada por tinci\u00f3n con FITC-faloidina se indujo en fibroblastos tratados con BPC 157. La expresi\u00f3n de prote\u00ednas y la activaci\u00f3n de FAK y paxilina se determinaron mediante an\u00e1lisis de transferencia Western, y los niveles de fosforilaci\u00f3n tanto de FAK como de paxilina aumentaron de forma dependiente de la dosis mediante BPC 157, mientras que las cantidades totales de prote\u00edna permanecieron inalteradas. En conclusi\u00f3n, BPC 157 promueve el crecimiento ex vivo de fibroblastos de tend\u00f3n a partir de explantes de tend\u00f3n, la supervivencia celular bajo estr\u00e9s y la migraci\u00f3n in vitro de fibroblastos de tend\u00f3n, que probablemente est\u00e9 mediada por la activaci\u00f3n de la v\u00eda FAK-paxilina.
\n <& > Aplicaciones de Tesamorelin<\/strong> <\/p>\n

1. La triptorelina aumenta los niveles de testosterona al provocar una estimulaci\u00f3n constante de la pituitaria, disminuye la secreci\u00f3n hipofisaria de gonadotropinas, hormona luteinizante (LH) y hormona estimulante del fol\u00edculo (FSH). <\/p>\n

2. Al igual que otros agonistas de GnRH, la triptorelina se puede utilizar en el tratamiento de c\u00e1nceres que responden a hormonas, como el c\u00e1ncer de pr\u00f3stata o de mama, la pubertad precoz, las afecciones dependientes de estr\u00f3genos (como la endometriosis o los fibromas uterinos) y en la reproducci\u00f3n asistida.<\/p>\n","protected":false},"excerpt":{"rendered":"

Nombre del producto: Tesamorelin (usan)
\n CAS: 218949-48-5
\n EINECS: 603-809-2
\n Archivo Mol: Archivo Mol<\/p>\n","protected":false},"featured_media":2174,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[523],"product_tag":[2068],"class_list":{"0":"post-7721","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-otros-peptidos","7":"product_tag-tesamorelin-usan-tesamorelin-cas-218949-48-5-for-the-treatment-of-hiv-associated-lipid-metabolism-disorder-syndrome-es","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product\/7721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/comments?post=7721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/media\/2174"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/media?parent=7721"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_brand?post=7721"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_cat?post=7721"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_tag?post=7721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}